Unstable angina
Conditions
Interventions
Experimental group:Standardized Western medicine treatment + Qi Dan Yi Qi Decoction (Standard Dosage)
control group:Standard Western medical treatment combined with Qiyi Yiqi Decoction (low dose)
Sponsors
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University
Eligibility
Sex/Gender
All
Age
35 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1)Age between 35 and 75 gender (2) Meet the diagnostic criteria for UA and meet one of the following three conditions: 1) Coronary angiography or coronary CT angiography confirms coronary heart disease; 2) Previous coronary revascularization treatment; 3) History of old myocardial infarction; (3) CCS angina classification is grade I-III; (4) Traditional Chinese Medicine diagnosis of Qi deficiency and blood stasis syndrome; (5) Signed informed consent form.
Exclusion criteria
Exclusion criteria: Patients who are pregnant or breastfeeding; those allergic to the trial drug components; those with severe heart failure (left ventricular ejection fraction < 30%) or serious arrhythmias (such as rapid atrial fibrillation ventricular fibrillation or ventricular tachycardia) or other heart diseases (valvular heart disease dilated cardiomyopathy restrictive cardiomyopathy cor pulmonale congenital heart disease etc.); those with severe infections chronic obstructive diseases respiratory failure or pulmonary heart disease; those with severe primary liver kidney or blood system diseases malignant tumors or severe mental illnesses or uncontrollable systemic diseases; those with severe metabolic disorders (such as hyperthyroidism diabetic ketoacidosis); those planning coronary artery revascularization within 30 days; or those currently using traditional Chinese medicines similar in composition or function to the study medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TyG index;Seattle Angina QuestionnaireSAQ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Creatine Kinase-Myocardial Band;Fasting blood glucose;Total Cholesterol;Low Density Lipoprotein-Cholesterol;Optimal antiplatelet Therapy for Chinese patients with Coronary Artery Disease;Triglycerides;Hospital Anxiety and Depression Scale;High Density Lipoprotein-Cholesterol;Prediction of Bleeding Risk in Dual Antiplatelet Therapy;Creatine Kinase;Traditional Chinese Medicine syndrome scoring; | — |
Countries
China
Contacts
Public ContactQiu Shenglei
Beijing TCM Hospital Affiliated with Capital Medical University
Outcome results
None listed